Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $84.1 million.

  • Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments rose 7467.43% to $84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.2 million, marking a year-over-year increase of 2406.41%. This contributed to the annual value of $239.9 million for FY2024, which is 3671.21% up from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $84.1 million, which was up 7467.43% from $30.6 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments registered a high of $139.2 million during Q1 2021, and its lowest value of $7.5 million during Q1 2022.
  • Its 5-year average for Change in Acquisitions & Divestments is $53.1 million, with a median of $46.0 million in 2023.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments crashed by 9461.4% in 2022 and then surged by 31256.0% in 2024.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $10.0 million in 2021, then soared by 101.0% to $20.1 million in 2022, then surged by 128.75% to $46.0 million in 2023, then skyrocketed by 90.26% to $87.5 million in 2024, then decreased by 3.89% to $84.1 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $84.1 million for Q3 2025, versus $30.6 million for Q2 2025 and $44.0 million for Q1 2025.